Seagen had a market capitalization of roughly $30 billion, as of Friday's close., in a deal that would have been worth $40 billion or more, the Journal reported last year, but the two sides failed to reach an agreement, according to multiple reports.
Seagen's shares have fallen nearly 10% since July, when the deal talks with Merck were first reported. They rose 12.3% to $182 in premarket trading on Monday. Pfizer declined to comment on the WSJ report, while Seagen did not immediately respond to a Reuters request for comment.it expects to lose $17 billion in annual sales between 2025 and 2030 due to patent expirations for top drugs, and sales of its COVID-19 products have begun to decline after they contributed to an unprecedented surge in revenue.
Of course this evil drug maker wants their paws in everything. Are they going to find a cure . Probably not eh . Money money money. Greedy corrupt bastards
Well that is their business model…create the health crisis and then sell the drug to fix it….or make it worse whatever….either way it’s win win.
Of course.
Probably so they can run it into the ground.
Which means there will never be a cancer drug that cures cancer 100p.
abigail_fekete well well well
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 BillionBreaking: Pfizer is in early-stage talks to acquire biotech Seagen, valued at about $30 billion, and its pioneering targeted cancer therapies So they can bury the research? Everyone knows that there is zero long term profit in a cure. It’s about keeping you returning for “treatments” for as long as possible. Ugh Thanks to us generous tax payers. Do we get to share in the profits?
Source: WSJ - 🏆 98. / 63 Read more »